With the 2020 legislative session underway, NORML chapters across the country are organizing lobby days to advocate for sensible reform policies in their state.
2019 has been an unprecedented year for the passage of state-level marijuana law reforms and when we zoom out, it’s remarkable to reflect upon what we have accomplished. That is why are proud to publish Marijuana Reform Is Normal, which is the only comprehensive report detailing all of our collective victories in 2019.
In the FY2020 appropriations package released Monday, existing protections for medical cannabis programs from federal prosecutors that have been in place since 2014 remained, but other amendments that had been added earlier in the year by House Democrats were removed from the final compromise.
Maine currently holds the record for taking the longest to roll out its marijuana retail program. What happened in the Pine Tree State, and how can the next states to legalize avoid what went down there?
Garden State NORML and cannabis consumers across New Jersey are calling on legislators to find an immediate solution to stop arresting nearly 100 people every day for possessing small amounts of marijuana.
The House Judiciary Committee just approved the MORE Act, legislation that tens-of-thousands advocated for by sending messages, making phone calls, and meeting with lawmakers in DC and district offices.
City Representatives Alexsandra Anello (District 2) and Dr. Sam Morgan (District 4) filed a resolution seeking to implement a Cite and Release program after working closely with members of El Paso NORML and LegalizEP.
The House Judiciary Committee has posted a markup date for HR 3884, the Marijuana Opportunity, Reinvestment, and Expungement (MORE) Act.
Lehigh Valley NORML, and medical cannabis patients from across Pennsylvania, will hold the second in a series of monthly protests at the Department of Health (PaDOH) headquarters on Forster St. “Patients First: Fixing Medical Marijuana in PA” will commence on Wednesday November 13, 2019 from 08:30 AM-5:00 PM.
Use of the term ‘cannabis’ instead of ‘marijuana’ does not influence the public’s perception of the plant or their attitudes, according to data published in the journal PLOS One. Investigators concluded: “We find no support for the notion that changing the name of the drug from ‘marijuana’ to ‘cannabis’ affects public opinion on the drug or the policies governing it.”